Royal Bank of Canada’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-80
| Closed | – | – | 7258 |
|
2023
Q3 | $0 | Sell |
80
-4
| -5% | – | ﹤0.01% | 7270 |
|
2023
Q2 | $0 | Buy |
84
+24
| +40% | – | ﹤0.01% | 7312 |
|
2023
Q1 | $0 | Buy |
+60
| New | – | ﹤0.01% | 7114 |
|
2022
Q2 | – | Sell |
-115
| Closed | -$6K | – | 7350 |
|
2022
Q1 | $6K | Sell |
115
-328
| -74% | -$17.1K | ﹤0.01% | 6733 |
|
2021
Q4 | $34K | Buy |
443
+283
| +177% | +$21.7K | ﹤0.01% | 6048 |
|
2021
Q3 | $12K | Buy |
160
+31
| +24% | +$2.33K | ﹤0.01% | 6390 |
|
2021
Q2 | $18K | Buy |
129
+4
| +3% | +$558 | ﹤0.01% | 6126 |
|
2021
Q1 | $27K | Sell |
125
-2,767
| -96% | -$598K | ﹤0.01% | 5768 |
|
2020
Q4 | $480K | Buy |
2,892
+92
| +3% | +$15.3K | ﹤0.01% | 3687 |
|
2020
Q3 | $476K | Buy |
+2,800
| New | +$476K | ﹤0.01% | 3467 |
|
2020
Q2 | – | Sell |
-2
| Closed | – | – | 6417 |
|
2020
Q1 | $0 | Sell |
2
-54
| -96% | – | ﹤0.01% | 6409 |
|
2019
Q4 | $8K | Buy |
56
+41
| +273% | +$5.86K | ﹤0.01% | 5631 |
|
2019
Q3 | $2K | Buy |
15
+14
| +1,400% | +$1.87K | ﹤0.01% | 5662 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6092 |
|